The Tiny Biotech Company That's Ending COVID 🦠

Its treatment has the potential to hand you an enormous windfall...

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Its treatment has the potential to hand you an enormous windfall...

                                                                                                     

Its treatment has the potential to hand you an enormous windfall...

                                                                                                     

Outsider Club's VIP Reserve: Outsider Club's VIP Reserve

PAID SUBSCRIBERS ONLY September 3, 2022 Dr. Anthony Fauci is officially retiring at the end of President Biden's term. "I don't think there is anything else that I, Tony Fauci, can do," he states. And what does he have to show for it? Well, he recently admitted that the vaccines are not as good as he touted. "Vaccines — because of the high degree of transmissibility of this virus — don't protect overly well against infection," Fauci reports. And now he's dreaming of sitting on a beach sipping cocktails in retirement. But COVID is still here, and it's a bigger threat than ever as new variants emerge. Like this deadly new "ninja variant"... And it has the potential to be the most contagious disease known to man. That's why we need a working COVID treatment NOW more than ever before. And while Fauci has failed us, there's one company that's working to clean up the mess he's leaving behind. It just finished creating a COVID-killing nasal spray... Which might just be the cure we've been looking for. It's easy to see why COVID vaccines can't hold a candle to this nasal spray. For starters, there are no pills and no fear or anxiety about getting stabbed with a needle. It also works FAST, making symptoms disappear within just seven days in early trials! And it stops ALL strains of COVID from spreading... As well as any newer, deadlier variants that pop up in the future. That's why I believe this is going to be in every medicine cabinet in America. In fact, I fully expect this to become more common than aspirin... Because you'd always be able to rely on this treatment when everything else fails. But the best part is the company behind this breakthrough is NOT some Big Pharma giant like Pfizer or Merck. It's TINY, with a share price of less than $1. And it has the potential to end COVID once and for all. This could hand you the biggest biotech windfall of the decade... So I urge you to act while there's still time. Keep reading for more details. To your wealth, Keith Kohl Investment Director, Topline Trader P.S. This nasal spray could be the breakthrough we've been waiting for to finally end the COVID-19 pandemic once and for all. It's expected to be even BETTER than the vaccine, taking only seven days to kill the COVID virus and stop symptoms. This medication is already in Phase 2 of its FDA trials, and if it gets fast-track approval, this stock could rise by many multiples over the next several months. That's why I'm recommending this small biotech company for immediate purchase.

---

This email was sent to indra21poetra@gmail.com. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may unsubscribe here, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Outsider Club's VIP Reserve, please add customerservice@outsiderclub.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. Outsider Club VIP Reserve, Copyright © 2022, Outsider Club LLC. All rights reserved. 3 E Read Street Baltimore, MD 21202. For customer service, call (855) 496-0830. The content of this site may not be redistributed without the express written consent of the Outsider Club. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and the Outsider Club as well as a link to www.outsiderclub.com. Your privacy is important to us. We will never rent or sell your e-mail or personal information. Please read our Privacy Policy. No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. Outsider Club does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. All Investments in Stocks, Options, Bonds, ETFs and Futures may carry a significant risk of loss.